Superior neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia

Stroke

Volumn 28, Issue 10, 1997, Pages 2018-2024

  Schmid Elsaesser, Robert ^a   Zausinger, Stefan ^a   Hungerhuber, Edwin ^a   Plesnila, Nikolaus ^a   Baethmann, Alexander ^a   Reulen, Hanns Juergen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cerebral ischemia, focal; Free radicals; Lipid peroxidation; Neuroprotection; Rats

Indexed keywords

6,7,8,9 TETRAHYDRO 9 (2 MORPHOLINOETHYL) 2,4 BIS(1 PYRROLIDINYL) 5H PYRIMIDO[4,5 B]INDOLE; ANTIOXIDANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; BRAIN PROTECTION; DRUG EFFECT; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

EID: 0030716503     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.10.2018     Document Type: Article

References (63)

1. Siesjö BK, Agardh CD, Bengtsson F. Free radicals and brain damage. Cerebrovasc Brain Metab Rev. 1989;1:165-211.
2. Braughler JM, Hall ED. Central nervous system trauma and stroke, I: biochemical considerations for oxygen radical formation and lipid peroxidalion. Free Radic Biol Med. 1989;6:289-301.
3. Braughler JM, Hall ED, Jacobsen EJ, McCall JM, Means ED. The 21-aminosteroids: potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs Future. 1989;14:143-152.
4. Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol. 1994;28:221-268.
5. Hall ED. Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J Neurol Sci. 1995;134:79-83.
6. Kassell NF, Haley EC, Appersonhansen C, Stat M, Alves WM, Dorsch NW, Fabinyi G, Matheson J, Reilly P, Siu K, Stokes B, Stuart G, Koos W, Calliauw L, Selosse P, Astrup J, Gjerris F, Mendelow AD, Castel JP, Christiaens JL, Cophignon J, Keravel Y, Lagarrigue J, Mourier K, Philippon J, Brandt L, Vonessen C, Persson L, Brock M, Fahlbusch P, Gilsbach J, Hassler W, Perneczky A, Samii M, Schmiedek P, Mee E, Arista A, Cantore G, Carteri A, Collice M, Dapian R, Marini G, Menonna P, Baena RRY, Matteo PS, Testa PC, Villani R, Antunes JL. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg. 1996;84:221-228.
7. Raub TJ, Barsuhn CL, Williams LR, Decker DE, Sawada GA, Ho NF. Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers. J Drug Target. 1993;1:269-286.
8. Hall ED, Andrus PK, Smith SL, Oostveen JA, Scherch HM, Lutzke BS, Raub TJ, Sawada GA, Palmer JR, Banitt LS, Tustin JS, Belonga KL, Aver DE, Bundy GL. Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants. Acta Neurochir Suppl (Wien). 1996;66:107-113.
9. Grammas P, Liu GJ, Wood K, Floyd RA. Anoxia/reoxygenation induces hydroxyl free radical formation in brain microvessels. Free Radic Biol Med. 1993;14:553-557.
10. Kumar M, Liu GJ, Floyd RA, Grammas P. Anoxic injury of endothelial cells increases production of nitric oxide and hydroxyl radicals. Biochem Biophys Res Commun. 1996;219:497-501.
11. McKinney JS, Willoughby KA, Liang S, Ellis EF. Stretch-induced injury of cultured neuronal, glial, and endothelial cells. Stroke. 1996;27:934-940.
12. Siesjö BK, Zhao Q, Pahlmark K, Siesjö P, Katsura K, Folbergrova J. Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann Thorac Surg. 1995;59:1316-1320.
13. Traystman RJ, Kirsch JR, Koehler RC. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol. 1991;71:1185-1195.
14. Schmid-Elsaesser R, Zausinger S, Baethmann A, Reulen HJ. Effect of a brain-penetrating (U-101033E) antioxidant on infarct size and outcome after focal cerebral ischemia. Cerebrovasc Dis. 1996; 6(suppl 2):43. Abstract.
15. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema, I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke. 1986;8:1-8.
16. Schmid-Elsaesser R, Zausinger S, Baethmann A, Reulen HJ. Subarachnoid hemorrhage in an experimental model of focal cerebral ischemia. Int J Microcirc Clin Exp. 1996;16(suppl 1):225. Abstract.
17. Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke. 1995;26:1086-1091.
18. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472-476.
19. Memezawa H, Zhao Q, Smith ML, Siesjö BK. Hyperthermia nullifies the ameliorating effect of dizocilpine maleate (MK-801) in focal cerebral ischemia. Brain Res. 1995;670:48-52.
20. Zhao Q, Memezawa H, Smith ML, Siesjö BK. Hyperthermia complicates middle cerebral artery occlusion induced by an intraluminal filament. Brain Res. 1994;649:253-259.
21. Pellegrino LJ. A Stereotaxic Atlas of the Rat Brain. New York, NY: Plenum Press; 1979.
22. Müller TB, Haraldseth O, Unsgard G. Characterization of the microcirculation during ischemia and reperfusion in the penumbra of a rat model of temporary middle cerebral artery occlusion: a laser Doppler flowmetry study. Int J Microcirc Clin Exp. 1994;14:289-295.
23. Karibe H, Chen J, Zarow GJ, Graham SH, Weinstein PR. Delayed induction of mild hypothermia to reduce infarct volume after temporary middle cerebral artery occlusion in rats. J Neurosurg. 1994; 80:112-119.
24. Karibe H, Zarow GJ, Graham SH, Weinstein PR. Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1994;14:620-627.
25. Tayarani I, Chaudiere J, Lefauconnier JM, Bourre JM. Enzymatic protection against peroxidative damage in isolated brain capillaries. J Neurochem. 1987;48:1399-1402.
26. Slater TF. Free-radical mechanisms in tissue injury. Biochem J. 1984;222:1-15.
27. Kontos HA, Wei EP, Ellis EF, Jenkins LW, Povlishock JT, Rowe GT, Hess ML. Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis in cats. Circ Res. 1985;57:142-151.
28. Kontos CD, Wei EP, Williams JI, Kontos HA, Povlishock JT. Cytochemical detection of superoxide in cerebral inflammation and ischemia in vivo. Am J Physiol. 1992;263:H1234-1242.
29. 2 synthetase or 5-lipoxygenase. CNS Trauma. 1986;2:75-83.
30. Hall ED, Andrus PK, Yonkers PA, Smith SL, Zhang J, Taylor BM, Sun FF. Generation and detection of hydroxyl radical following experimental head injury. Ann N Y Acad Sci. 1994;738:15-24.
31. Ginsberg MD. Neuroprotection in brain ischemia: an update (part II). Neuroscientist. 1995;1:164-175.
32. Piantadosi CA, Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke. 1996;27: 327-331.
33. Moore LE, Traystman RJ. Role of oxygen free radicals and lipid peroxidation in cerebral reperfusion injury. Adv Pharmacol. 1994; 31:565-576.
34. Folbergrova J, Zhao O, Katsura K, Siesjö BK. N-Tert-butyl-alpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc Natl Acad Sci U S A. 1995;92: 5057-5061.
35. Forsman M, Fleischer JE, Milde JH, Steen PA, Michenfelder JD. Superoxide dismutase and catalase failed to improve neurologic outcome after complete cerebral ischemia in the dog. Acta Anaesthesiol Scand. 1988;32:152-155.
36. Schürer L, Grogaard B, Gerdin B, Arfors KE. Superoxide dismutase does not prevent delayed hypoperfusion after incomplete cerebral ischaemia in the rat. Acta Neurochir (Wien). 1990;103:163-170.
37. Schürer L, Grogaard B, Gerdin B, Arfors KE. Effects of neutrophil depletion and superoxide dismutase on postischemic hypoperfusion of rat brain. Adv Neurol. 1990;52:57-62.
38. Clemens JA, Panetta JA. Neuroprotection by antioxidants in models of global and focal ischemia. Ann N Y Acad Sci. 1994;738: 250-256.
39. Chan PH, Kamii H, Yang GY, Gafni J, Epstein CJ, Carlson E, Reola L. Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. Neuroreport. 1993;5:293-296.
40. Yang GY, Chan PH, Chen J, Carlson E, Chen SF, Epstein P, Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 1994;25:165-170.
41. Chan PH. Role of oxidants in ischemic brain damage. Stroke. 1996; 27:1124-1129.
42. Imaizumi S, Woolworth V, Fishman RA, Chan PH. Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke. 1990;21:1312-1317.
43. Martz D, Beer M, Betz AL. Dimethylthiourea reduces ischemic brain edema without affecting cerebral blood flow. J Cereb Blood Flow Metab. 1990;10:352-357.
44. Soloniuk DS, Perkins E, Wilson JR. Use of allopurinol and deferoxamine in cellular protection during ischemia. Surg Neurol. 1992; 38:110-113.
45. Martz D, Rayos G, Schielke GP, Betz AL. Allopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in rats. Stroke. 1989;20:488-494.
46. Haun SE, Kirsch JR, Helfaer MA, Kubos KL, Traystman RJ. Polyethylene glycol-conjugated superoxide dismutase fails to augment brain superoxide dismutase activity in piglets. Stroke. 1991; 22:655-659.
47. Helfaer MA, Kirsch JR, Haun SE, Moore LE, Traystman RJ. Polyethylene glycol-conjugated superoxide dismutase fails to blunt postischemic reactive hyperemia. Am J Physiol. 1991;261:H548-H553.
48. Xue D, Slivka A, Buchan AM. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats. Stroke. 1992;23:894-899.
49. He YY, Hsu CY, Ezrin AM, Miller MS. Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion. Am J Physiol. 1993;265:H252-H256.
50. Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol. 1989;256:H589-H593.
51. Zhao Q, Pahlmark K, Smith ML, Siesjö BK. Delayed treatment with the spin trap a-phenyl-N-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats. Acta Physiol Scand. 1994;152:349-350.
52. Cao XH, Phillis JW. Alpha-phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 1994;644:267-272.
53. Cheng HY, Liu T, Feuerstein G, Barone FC. Distribution of spin-trapping compounds in rat blood and brain: in vivo microdialysis determination. Free Radic Biol Med. 1993;14:243-250.
54. Phillis JW, Clough Helfman C. Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-alpha-phenylnitrone (PBN). Neurosci Lett. 1990;116:315-319.
55. Sakamoto A, Ohnishi ST, Ohnishi T, Ogawa R. Protective effect of a new anti-oxidant on the rat brain exposed to ischemia-reperfusion injury: inhibition of free radical formation and lipid peroxidation. Free Radic Biol Med. 1991;11:385-391.
56. Memezawa H, Minamisawa H, Smith ML, Siesjö BK. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res. 1992;89:67-78.
57. Siesjo BK, Katsura K, Zhao Q, Folbergrova J, Pahlmark K, Siesjo P, Smith ML. Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J Neurotrauma. 1995;12: 943-956.
58. Chen J, Weinstein PR, Graham SH. Attenuation of postischemic brain hypoperfusion and reperfusion injury by the cyclooxygenase-lipoxygenase inhibitor BW755C. J Neurosurg. 1995;83:99-104.
59. Hall ED, Yonkers PA. Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke. 1988;19: 340-344.
60. Maruki Y, Koehler RC, Kirsch JR, Blizzard KK, Traystman RJ. Tirilazad pretreatment improves early cerebral metabolic and blood flow recovery from hyperglycemic ischemia. J Cereb Blood Flow Metab. 1995;15:88-96.
61. Matsumiya N, Koehler RC, Kirsch JR, Traystman RJ. Conjugated superoxide dismutase reduces extent of caudate injury after transient focal ischemia in cats. Stroke. 1991;22:1193-1200.
62. Müller TB, Haraldseth O, Jones RA, Sebastiani G, Lindboe CF, Unsgard G, Oksendal AN. Perfusion and diffusion-weighted MR imaging for in vivo evaluation of treatment with U74389G in a rat stroke model. Stroke. 1995;26:1453-1458.
63. Betz AL, Randall J, Martz D. Xanthine oxidase is not a major source of free radicals in focal cerebral ischemia. Am J Physiol. 1991;260:H563-H568.